When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
RARX - Ra pharmaceuticals launches late-stage zilucoplan trial for gMG
Ra Pharmaceuticals Inc.
Ra Pharmaceuticals (NASDAQ:RARX) initiates dosing in the RAISE study, its pivotal, Phase 3 clinical trial evaluating zilucoplan for the treatment of generalized myasthenia gravis (gMG).
More news on: Ra Pharmaceuticals, Inc., Healthcare stocks news,